Unknown location
拓济医药 completed a Series A financing of nearly $40 million. 拓济医药 is a developer of antibody-drug conjugates.
元禾原点, 德诚资本, 龙磐投资, 济峰资本, 幂方健康基金, 松青资本, 建发新兴投资